These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10357499)

  • 1. Survival versus years of healthy life: which is more powerful as a study outcome?
    Diehr P; Patrick DL; Burke GL; Williamson J
    Control Clin Trials; 1999 Jun; 20(3):267-79. PubMed ID: 10357499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect size and power for clinical trials that measure years of healthy life.
    Diehr P; Psaty BM; Patrick DL
    Stat Med; 1997 Jun; 16(11):1211-23. PubMed ID: 9194268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight-modification trials in older adults: what should the outcome measure be?
    Diehr P; Newman AB; Jackson SA; Kuller L; Powe N
    Curr Control Trials Cardiovasc Med; 2002 Jan; 3(1):1. PubMed ID: 11985775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
    Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analysis techniques in angina pectoris trials.
    Bristol DR; Castellana JV
    Stat Med; 1990 Mar; 9(3):293-9. PubMed ID: 2188327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
    King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
    Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the minimal clinically important difference for health-related quality-of-life outcomes: a comparison of sample size requirements for an incontinence treatment trial.
    Halme AS; Fritel X; Benedetti A; Eng K; Tannenbaum C
    Value Health; 2015 Mar; 18(2):292-8. PubMed ID: 25773565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical outcome after coronary bypass surgery: a 30-year follow-up study.
    van Domburg RT; Kappetein AP; Bogers AJ
    Eur Heart J; 2009 Feb; 30(4):453-8. PubMed ID: 19066209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up.
    Lee HY; Hwang JS; Jeng JS; Wang JD
    Stroke; 2010 Apr; 41(4):739-44. PubMed ID: 20150543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating mortality and morbidity outcomes: using quality-adjusted life years in critical care trials.
    Ferguson ND; Scales DC; Pinto R; Wilcox ME; Cook DJ; Guyatt GH; Schünemann HJ; Marshall JC; Herridge MS; Meade MO;
    Am J Respir Crit Care Med; 2013 Feb; 187(3):256-61. PubMed ID: 23204250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific prevalence and years of healthy life in a system with three health states.
    Diehr P; Yanez D; Derleth A; Newman AB
    Stat Med; 2008 Apr; 27(9):1371-86. PubMed ID: 17847058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME).
    Pfisterer M;
    Circulation; 2004 Sep; 110(10):1213-8. PubMed ID: 15337691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measure-dependent variation in burden of disease estimates: implications for policy.
    Gold MR; Muennig P
    Med Care; 2002 Mar; 40(3):260-6. PubMed ID: 11880798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACTION with nifedipine GITS (Adalat XL) provides evidence for safety and improved outcome in angina patients.
    Cardiovasc J S Afr; 2004; 15(5):249-51. PubMed ID: 15483737
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative efficiency and sample size for cluster randomized trials with variable cluster sizes.
    You Z; Williams OD; Aban I; Kabagambe EK; Tiwari HK; Cutter G
    Clin Trials; 2011 Feb; 8(1):27-36. PubMed ID: 21163852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
    J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.